688065 凯赛生物
已收盘 12-18 15:00:00
资讯
新帖
简况
凯赛生物：公司2025年前三季度营业收入25.45亿元，同比增长14.90%
证券日报 · 11-25
凯赛生物：公司2025年前三季度营业收入25.45亿元，同比增长14.90%
凯赛生物：公司2025年前三季度产品销售量同比增长
证券日报 · 11-25
凯赛生物：公司2025年前三季度产品销售量同比增长
11月25日凯赛生物现1笔折价20.85%的大宗交易 合计成交4324.06万元
证券之星 · 11-25
11月25日凯赛生物现1笔折价20.85%的大宗交易 合计成交4324.06万元
每周股票复盘：凯赛生物（688065）2025年员工持股计划完成非交易过户
证券之星 · 11-23
每周股票复盘：凯赛生物（688065）2025年员工持股计划完成非交易过户
凯赛生物（688065）披露高级管理人员变更及选举副董事长公告，11月21日股价下跌2.56%
证券之星 · 11-21
凯赛生物（688065）披露高级管理人员变更及选举副董事长公告，11月21日股价下跌2.56%
凯赛生物（688065）披露2025年员工持股计划首次授予部分非交易过户完成，11月19日股价下跌0.06%
证券之星 · 11-19
凯赛生物（688065）披露2025年员工持股计划首次授予部分非交易过户完成，11月19日股价下跌0.06%
凯赛生物：关于募投项目延期事项详见公司于2025年9月30日披露的《关于部分募投项目延期的公告》
证券日报 · 10-31
凯赛生物：关于募投项目延期事项详见公司于2025年9月30日披露的《关于部分募投项目延期的公告》
凯赛生物(688065)9月30日股东户数1.5万户，较上期增加28%
证券之星 · 10-31
凯赛生物(688065)9月30日股东户数1.5万户，较上期增加28%
图解凯赛生物三季报：第三季度单季净利润同比增长45.30%
证券之星 · 10-31
图解凯赛生物三季报：第三季度单季净利润同比增长45.30%
凯赛生物（688065）披露关于股份回购实施结果暨股份变动的公告，10月20日股价下跌0.21%
证券之星 · 10-20
凯赛生物（688065）披露关于股份回购实施结果暨股份变动的公告，10月20日股价下跌0.21%
每周股票复盘：凯赛生物（688065）完成股份回购，金额超1094万元
证券之星 · 10-19
每周股票复盘：凯赛生物（688065）完成股份回购，金额超1094万元
凯赛生物（688065）披露2025年员工持股计划草案，10月15日股价上涨0.1%
证券之星 · 10-15
凯赛生物（688065）披露2025年员工持股计划草案，10月15日股价上涨0.1%
每周股票复盘：凯赛生物（688065）回购进展披露
证券之星 · 10-12
每周股票复盘：凯赛生物（688065）回购进展披露
凯赛生物（688065）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价上涨1.27%
证券之星 · 10-09
凯赛生物（688065）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价上涨1.27%
凯赛生物(688065.SH)拟推2025年员工持股计划
智通财经 · 09-29
凯赛生物(688065.SH)拟推2025年员工持股计划
凯赛生物最新公告：年产50万吨生物基戊二胺及90万吨生物基聚酰胺项目延期至2027年12月31日
证券之星 · 09-29
凯赛生物最新公告：年产50万吨生物基戊二胺及90万吨生物基聚酰胺项目延期至2027年12月31日
每周股票复盘：凯赛生物（688065）将召开2025年半年度业绩说明会
证券之星 · 09-21
每周股票复盘：凯赛生物（688065）将召开2025年半年度业绩说明会
凯赛生物（688065）披露召开2025年半年度业绩说明会公告，9月17日股价下跌0.13%
证券之星 · 09-17
凯赛生物（688065）披露召开2025年半年度业绩说明会公告，9月17日股价下跌0.13%
9月8日凯赛生物涨6.87%，博时上证科创板新材料ETF基金重仓该股
证券之星 · 09-08
9月8日凯赛生物涨6.87%，博时上证科创板新材料ETF基金重仓该股
凯赛生物涨6.87%，华安证券二周前给出“买入”评级
证券之星 · 09-08
凯赛生物涨6.87%，华安证券二周前给出“买入”评级
公司概况
公司名称：
上海凯赛生物技术股份有限公司
所属行业：
化学纤维制造业
上市日期：
2020-08-12
主营业务：
上海凯赛生物技术股份有限公司的主营业务是新型生物基材料的研发、生产及销售。公司的主要产品是系列生物法长链二元酸（DC10-DC18）、生物基戊二胺、系列生物基聚酰胺、生物基连续纤维热塑型复合材料（Bio-PPACFRT）。
发行价格：
133.45
{"stockData":{"symbol":"688065","market":"SH","secType":"STK","nameCN":"凯赛生物","latestPrice":47.25,"timestamp":1766041200000,"preClose":47.24,"halted":0,"volume":1957885,"delay":0,"changeRate":0.0002,"floatShares":583000000,"shares":721000000,"eps":0.8242,"marketStatus":"已收盘","change":0.01,"latestTime":"12-18 15:00:00","open":47.24,"high":47.64,"low":47.03,"amount":92648000,"amplitude":0.0129,"askPrice":47.25,"askSize":8,"bidPrice":47.24,"bidSize":17,"shortable":0,"etf":0,"ttmEps":0.8242,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766107800000},"marketStatusCode":5,"adr":0,"adjPreClose":47.24,"symbolType":"stock_kcb","openAndCloseTimeList":[[1766021400000,1766028600000],[1766034000000,1766041200000]],"highLimit":51.96,"lowLimit":42.52,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":721289794,"isCdr":false,"pbRate":1.94,"roa":"--","peRate":57.328318,"roe":"2.89%","epsLYR":0.84,"committee":-0.6469,"marketValue":34081000000,"turnoverRate":0.0034,"status":0,"afterMarket":{"amount":0,"volume":0,"close":47.25,"buyVolume":0,"sellVolume":0,"time":1766043237768,"indexStatus":"已收盘 12-18 15:30:00","preClose":47.24},"floatMarketCap":27565000000},"requestUrl":"/m/hq/s/688065/wiki","defaultTab":"wiki","newsList":[{"id":"2586478396","title":"凯赛生物：公司2025年前三季度营业收入25.45亿元，同比增长14.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586478396","media":"证券日报 ","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586478396?lang=zh_cn&edition=full","pubTime":"2025-11-25 19:33","pubTimestamp":1764070380,"startTime":"0","endTime":"0","summary":"证券日报网讯凯赛生物11月25日在互动平台回答投资者提问时表示，公司2025年前三季度营业收入25.45亿元，同比增长14.90%，净利润4.51亿元，同比增长30.56%。公司积极推动系列生物基聚酰胺及其复合材料的应用开发，会同招商局集团及各领域下游合作伙伴，合力推动生物制造产业生态圈的建设。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-25/doc-infyrmit4746603.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-25/doc-infyrmit4746603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688065"],"gpt_icon":0},{"id":"2586147834","title":"凯赛生物：公司2025年前三季度产品销售量同比增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2586147834","media":"证券日报 ","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586147834?lang=zh_cn&edition=full","pubTime":"2025-11-25 19:33","pubTimestamp":1764070380,"startTime":"0","endTime":"0","summary":"郑重声明：东方财富发布此内容旨在传播更多信息，与本站立场无关，不构成投资建议。据此操作，风险自担。 \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-25/doc-infyrmiw4026217.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-25/doc-infyrmiw4026217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2586262444","title":"11月25日凯赛生物现1笔折价20.85%的大宗交易 合计成交4324.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586262444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586262444?lang=zh_cn&edition=full","pubTime":"2025-11-25 17:52","pubTimestamp":1764064367,"startTime":"0","endTime":"0","summary":"证券之星消息，11月25日凯赛生物发生大宗交易，交易数据如下：大宗交易成交价格38.46元，相对当日收盘价折价20.85%，成交112.43万股，成交金额4324.06万元，买方营业部为长城证券股份有限公司重庆新南路证券营业部，卖方营业部为长城证券股份有限公司重庆新南路证券营业部。近三个月该股共发生1笔大宗交易，合计成交1.12万手，折价成交1笔。截至2025年11月25日收盘，凯赛生物报收于48.59元，上涨1.08%，换手率0.59%，成交量3.46万手，成交额1.69亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500027257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2585210687","title":"每周股票复盘：凯赛生物（688065）2025年员工持股计划完成非交易过户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585210687","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585210687?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:24","pubTimestamp":1763843050,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，凯赛生物报收于47.9元，较上周的50.2元下跌4.58%。公司公告汇总关于2025年员工持股计划首次授予部分非交易过户完成的公告上海凯赛生物技术股份有限公司2025年员工持股计划首次授予部分已完成非交易过户。该部分股份已于2025年11月17日由公司回购专用证券账户非交易过户至员工持股计划专用账户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2585141363","title":"凯赛生物（688065）披露高级管理人员变更及选举副董事长公告，11月21日股价下跌2.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585141363","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585141363?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:49","pubTimestamp":1763736592,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，凯赛生物报收于47.9元，较前一交易日下跌2.56%，最新总市值为345.5亿元。该股当日开盘48.89元，最高49.88元，最低47.65元，成交额达2.1亿元，换手率为0.75%。近日，凯赛生物发布公告称，公司于2025年11月21日召开第三届董事会第四次会议，同意XIUCAI LIU（刘修才）先生辞去公司总裁职务，其辞职报告自送达董事会之日起生效。此外，董事会选举臧慧卿女士为第三届董事会副董事长，任期至本届董事会任期届满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100040982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2584294790","title":"凯赛生物（688065）披露2025年员工持股计划首次授予部分非交易过户完成，11月19日股价下跌0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584294790","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584294790?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:32","pubTimestamp":1763562738,"startTime":"0","endTime":"0","summary":"截至2025年11月19日收盘，凯赛生物报收于49.64元，较前一交易日下跌0.06%，最新总市值为358.05亿元。近日，凯赛生物发布关于2025年员工持股计划首次授予部分非交易过户完成的公告。该部分股份已于2025年11月17日由公司回购专用证券账户非交易过户至员工持股计划专用账户。员工持股计划存续期为48个月，标的股票分两期解锁，每期解锁比例均为50%，解锁时点分别为股票过户完成之日起满12个月、24个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900040176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2579149394","title":"凯赛生物：关于募投项目延期事项详见公司于2025年9月30日披露的《关于部分募投项目延期的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2579149394","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579149394?lang=zh_cn&edition=full","pubTime":"2025-10-31 22:09","pubTimestamp":1761919740,"startTime":"0","endTime":"0","summary":"证券日报网讯凯赛生物10月31日在互动平台回答投资者提问时表示，关于募投项目延期事项详见公司于2025年9月30日披露的《关于部分募投项目延期的公告》（公告编号：2025-050）。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-31/doc-infvvcym5382686.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-31/doc-infvvcym5382686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2579530451","title":"凯赛生物(688065)9月30日股东户数1.5万户，较上期增加28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579530451","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579530451?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:32","pubTimestamp":1761903174,"startTime":"0","endTime":"0","summary":"证券之星消息，近日凯赛生物披露，截至2025年9月30日公司股东户数为1.5万户，较6月30日增加3280.0户，增幅为28.0%。在化学制品行业个股中，凯赛生物股东户数低于行业平均水平，截至9月30日，化学制品行业平均股东户数为2.8万户。从股价来看，2025年6月30日至2025年9月30日，凯赛生物区间涨幅为11.41%，在此期间股东户数增加3280.0户，增幅为28.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100036776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2579402175","title":"图解凯赛生物三季报：第三季度单季净利润同比增长45.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579402175","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579402175?lang=zh_cn&edition=full","pubTime":"2025-10-31 02:48","pubTimestamp":1761850133,"startTime":"0","endTime":"0","summary":"证券之星消息，凯赛生物2025年三季报显示，前三季度公司主营收入25.45亿元，同比上升14.9%；归母净利润4.51亿元，同比上升30.56%；扣非净利润4.29亿元，同比上升27.83%；其中2025年第三季度，公司单季度主营收入8.74亿元，同比上升13.43%；单季度归母净利润1.42亿元，同比上升45.3%；单季度扣非净利润1.32亿元，同比上升38.25%；负债率9.5%，投资收益-422.24万元，财务费用-9898.76万元，毛利率34.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100003059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065"],"gpt_icon":0},{"id":"2576834715","title":"凯赛生物（688065）披露关于股份回购实施结果暨股份变动的公告，10月20日股价下跌0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576834715","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576834715?lang=zh_cn&edition=full","pubTime":"2025-10-20 17:11","pubTimestamp":1760951486,"startTime":"0","endTime":"0","summary":"截至2025年10月20日收盘，凯赛生物报收于47.35元，较前一交易日下跌0.21%，最新总市值为341.53亿元。该股当日开盘48.08元，最高48.29元，最低47.07元，成交额达1.25亿元，换手率为0.45%。公司近日发布公告称，上海凯赛生物技术股份有限公司于2024年10月21日召开董事会，审议通过以集中竞价交易方式回购股份的方案，回购期限为2024年10月21日至2025年10月20日，拟回购金额为1,000万元至2,000万元，价格不超过67元/股。本次回购不影响公司控制权及上市地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000021605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2576049648","title":"每周股票复盘：凯赛生物（688065）完成股份回购，金额超1094万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576049648","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576049648?lang=zh_cn&edition=full","pubTime":"2025-10-19 03:30","pubTimestamp":1760815828,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，凯赛生物报收于47.45元，较上周的52.59元下跌9.77%。本周，凯赛生物10月14日盘中最高价报52.8元。股本股东变化：公司完成股份回购，实际回购239,201股，支付资金总额10,941,373.03元。公司公告汇总上海市锦天城律师事务所对上海凯赛生物技术股份有限公司2025年第三次临时股东会出具法律意见书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2575065735","title":"凯赛生物（688065）披露2025年员工持股计划草案，10月15日股价上涨0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575065735","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575065735?lang=zh_cn&edition=full","pubTime":"2025-10-15 22:24","pubTimestamp":1760538257,"startTime":"0","endTime":"0","summary":"截至2025年10月15日收盘，凯赛生物报收于50.17元，较前一交易日上涨0.1%，最新总市值为361.87亿元。该股当日开盘50.36元，最高50.92元，最低49.88元，成交额达1.64亿元，换手率为0.56%。出席会议的股东及代理人共145名，代表有表决权股份总数471,687,692股，占公司有表决权股份总数的65.6080%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500038224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2574450362","title":"每周股票复盘：凯赛生物（688065）回购进展披露","url":"https://stock-news.laohu8.com/highlight/detail?id=2574450362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574450362?lang=zh_cn&edition=full","pubTime":"2025-10-12 02:20","pubTimestamp":1760206823,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，凯赛生物报收于52.59元，较上周的52.04元上涨1.06%。本周，凯赛生物10月10日盘中最高价报52.91元。凯赛生物当前最新总市值379.33亿元，在化学制品板块市值排名6/169，在两市A股市值排名498/5158。本周关注点公司公告汇总：截至2025年9月30日，凯赛生物已回购股份230,366股，支付资金总额10,497,716.71元。公司公告汇总关于以集中竞价交易方式回购公司股份的进展公告证券代码：688065，证券简称：凯赛生物，公告编号：2025-057。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000535.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2574166636","title":"凯赛生物（688065）披露以集中竞价交易方式回购公司股份的进展公告，10月09日股价上涨1.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574166636","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574166636?lang=zh_cn&edition=full","pubTime":"2025-10-09 22:29","pubTimestamp":1760020155,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，凯赛生物报收于52.7元，较前一交易日上涨1.27%，最新总市值为380.12亿元。近日，凯赛生物发布关于以集中竞价交易方式回购公司股份的进展公告。公告显示，证券代码：688065，证券简称：凯赛生物，公告编号：2025-057。上海凯赛生物技术股份有限公司于2024年10月21日召开董事会审议通过回购股份方案，回购期限为2024年10月21日至2025年10月20日，拟回购金额为1,000万元至2,000万元，用于员工持股计划或股权激励，回购价格不超过67元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900034482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2571334231","title":"凯赛生物(688065.SH)拟推2025年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2571334231","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571334231?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:05","pubTimestamp":1759154756,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯赛生物 披露2025年员工持股计划(草案)，参加对象包括公司董事、高级管理人员、公司中层管理人员、技术(业务)骨干。员工持股计划拟持有的标的股票数量不超过130.00万股，约占员工持股计划草案公布时公司股本总额的0.18%。为满足公司可持续发展的需要及不断吸引和留住优秀人才，员工持股计划拟预留15.00万股作为预留份额，占员工持股计划股票总数的11.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1350908.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2571317103","title":"凯赛生物最新公告：年产50万吨生物基戊二胺及90万吨生物基聚酰胺项目延期至2027年12月31日","url":"https://stock-news.laohu8.com/highlight/detail?id=2571317103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571317103?lang=zh_cn&edition=full","pubTime":"2025-09-29 21:40","pubTimestamp":1759153210,"startTime":"0","endTime":"0","summary":"凯赛生物(688065.SH)公告称，公司于2025年9月29日召开第三届董事会第二次会议，审议通过了《关于部分募投项目延期的议案》，同意公司对募投项目“年产50万吨生物基戊二胺及90万吨生物基聚酰胺项目”达到预定可使用状态的时间进行延期。调整前预计2025年12月31日完成，现调整为2027年12月31日。此次延期是基于项目所在园区配套基础设施和投产条件尚未完善，符合相关法律法规和规范性文件的要求，不会对公司正常经营产生重大不利影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900034773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2569106243","title":"每周股票复盘：凯赛生物（688065）将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2569106243","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569106243?lang=zh_cn&edition=full","pubTime":"2025-09-21 02:10","pubTimestamp":1758391823,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，凯赛生物报收于51.88元，较上周的54.14元下跌4.17%。本周，凯赛生物9月15日盘中最高价报54.51元。凯赛生物当前最新总市值374.21亿元，在化学制品板块市值排名6/169，在两市A股市值排名479/5153。本周关注点公司公告汇总：凯赛生物将于2025年09月25日召开2025年半年度业绩说明会。投资者可于2025年09月18日至09月24日16:00前通过上证路演中心“提问预征集”栏目或公司邮箱cathaybiotech_info@cathaybiotech.com提交问题。说明会期间，投资者可通过上证路演中心在线参与并提问。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000387.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2568492935","title":"凯赛生物（688065）披露召开2025年半年度业绩说明会公告，9月17日股价下跌0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568492935","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568492935?lang=zh_cn&edition=full","pubTime":"2025-09-17 22:23","pubTimestamp":1758119000,"startTime":"0","endTime":"0","summary":"截至2025年9月17日收盘，凯赛生物报收于53.47元，较前一交易日下跌0.13%，最新总市值为385.67亿元。公司近日发布公告称，上海凯赛生物技术股份有限公司将于2025年09月25日（星期四）14:00-15:00通过上证路演中心以网络互动方式召开2025年半年度业绩说明会，介绍公司2025年半年度经营成果、财务状况等。投资者可于2025年09月18日至09月24日16:00前通过上证路演中心“提问预征集”栏目或公司邮箱cathaybiotech_info@cathaybiotech.com提交问题。说明会期间，投资者可通过上证路演中心在线参与并提问。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700040414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2565538501","title":"9月8日凯赛生物涨6.87%，博时上证科创板新材料ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2565538501","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565538501?lang=zh_cn&edition=full","pubTime":"2025-09-08 16:23","pubTimestamp":1757319837,"startTime":"0","endTime":"0","summary":"证券之星消息，9月8日凯赛生物涨6.87%创60日新高，收盘报55.69元，换手率1.44%，成交量8.41万手，成交额4.57亿元。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为博时基金的博时上证科创板新材料ETF。博时上证科创板新材料ETF目前规模为2.56亿元，最新净值0.7664，较上一交易日上涨6.08%，近一年上涨79.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800020574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["510300","159982","BK0208","000905.SH","510880","159967","000688.SH","399001","000001.SH","516480","399006","399300","688065","512880","512510","000300.SH","515890"],"gpt_icon":0},{"id":"2565583501","title":"凯赛生物涨6.87%，华安证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2565583501","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565583501?lang=zh_cn&edition=full","pubTime":"2025-09-08 16:23","pubTimestamp":1757319828,"startTime":"0","endTime":"0","summary":"今日凯赛生物涨6.87%，收盘报55.69元。2025年8月25日，华安证券研究员王强峰,刘天其发布了对凯赛生物的研报《25Q2业绩持续增长，生物基PA商业化放量在即》，该研报对凯赛生物给出“买入”评级。研报中预计公司2025-2027年归母净利润分别为6.86、8.49、11.22亿元，同比增速为40.2%、23.8%、32.1%。维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为长城证券的王彤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800020569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","688065"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766086687480,"stockEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":-0.0487},{"period":"3month","weight":-0.0892},{"period":"6month","weight":0.0052},{"period":"1year","weight":0.1122},{"period":"ytd","weight":0.228}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":-0.0161},{"period":"3month","weight":0.0147},{"period":"6month","weight":0.1537},{"period":"1year","weight":0.1461},{"period":"ytd","weight":0.1565}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海凯赛生物技术股份有限公司","boardCode":"AI0028","boardName":"化学纤维制造业","stockholders":"14994人(较上一季度增加28.00%)","perCapita":"38907股","listingDate":"2020-08-12","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路1690号5幢4楼","registeredCapital":"72128万元","survey":" 上海凯赛生物技术股份有限公司的主营业务是新型生物基材料的研发、生产及销售。公司的主要产品是系列生物法长链二元酸（DC10-DC18）、生物基戊二胺、系列生物基聚酰胺、生物基连续纤维热塑型复合材料（Bio-PPACFRT）。","listedPrice":133.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯赛生物,688065,凯赛生物股票,凯赛生物股票老虎,凯赛生物股票老虎国际,凯赛生物行情,凯赛生物股票行情,凯赛生物股价,凯赛生物股市,凯赛生物股票价格,凯赛生物股票交易,凯赛生物股票购买,凯赛生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}